Hepatoma Research Editorial Board Webinar
The first Editorial Board Webinar of Hepatoma Research, chaired by our Editor-in-Chief Prof. Guang-Wen Cao from China and Executive Chief Editor Prof. Giuliano Ramadori from Germany, was successfully held on March 24, 2021. The 7 invited speakers from the board reported and shared their recent research, there was a heated discussion in the meeting. Besides, the new progress of the journal and the existing problems to be addressed were reported and discussed. Many experts gave their constructive and valuable suggestions on the key points of the development of the journal.
Prof. David Geller, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Topic: Outcomes of laparoscopic liver resection for HCC
Prof. Xin-Yuan Guan, The University of Hong Kong, Hong Kong, China.
Topic: A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties
Prof. Antonio Bertoletti, Duke-NUS Graduate Medical School, Singapore City, Singapore.
Topic: Personalized T cell therapy in HBV-related HCC
Prof. Chun-Hong Ma, Shandong University, Jinan, Shandong, China.
Topic: Liver NK cells and hepatocellular carcinoma
Prof. Giuliano Ramadori, Gastroenterology and Endocrinology, University Medical Center Göttingen, Göttingen, Germany.
Topic: Changes in gene-exppression in the liver and other organs due to tissue damage in extrahepatic sites
Prof. Jin-Lin Hou, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, China.
Topic: aMAP risk score predicts HCC develop in hepatitis patients with different aetiologies: data from a global network
Prof. Georgios Tsoulfas, Aristoteleion University of Thessaloniki, Thessaloniki, Greece.
Topic: The Role of 3D Printing, Artificial Intelligence and Hololens in Liver Surgery
Report on Journal Development
Prof. Cao reported the new progress of the journal made in 2020 and the existing issues to be addressed in the following development. Many experts gave their constructive and valuable suggestions on the development of the journal. As the journal is riding steady and sound development momentum at present, there is no doubt that better results will be achieved in the near future.
Respectfully submitted by the Editorial Office of Hepatoma Research.